282 related articles for article (PubMed ID: 16785103)
1. Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting.
Singh BR
Neurotox Res; 2006 Apr; 9(2-3):73-92. PubMed ID: 16785103
[TBL] [Abstract][Full Text] [Related]
2. Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation.
Kumaran D; Eswaramoorthy S; Furey W; Navaza J; Sax M; Swaminathan S
J Mol Biol; 2009 Feb; 386(1):233-45. PubMed ID: 19118561
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a novel botulinum neurotoxin.
Zhang S; Masuyer G; Zhang J; Shen Y; Lundin D; Henriksson L; Miyashita SI; Martínez-Carranza M; Dong M; Stenmark P
Nat Commun; 2017 Aug; 8():14130. PubMed ID: 28770820
[TBL] [Abstract][Full Text] [Related]
4. Endopeptidase activities of botulinum neurotoxin type B complex, holotoxin, and light chain.
Wang HH; Riding S; Lindo P; Singh BR
Appl Environ Microbiol; 2010 Oct; 76(19):6658-63. PubMed ID: 20693440
[TBL] [Abstract][Full Text] [Related]
5. Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics.
Davies JR; Liu SM; Acharya KR
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30347838
[TBL] [Abstract][Full Text] [Related]
6. Unique ganglioside binding by botulinum neurotoxins C and D-SA.
Kroken AR; Karalewitz AP; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
FEBS J; 2011 Dec; 278(23):4486-96. PubMed ID: 21554541
[TBL] [Abstract][Full Text] [Related]
7. Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H.
Yao G; Lam KH; Perry K; Weisemann J; Rummel A; Jin R
Toxins (Basel); 2017 Mar; 9(3):. PubMed ID: 28282873
[TBL] [Abstract][Full Text] [Related]
8. Comparative role of neurotoxin-associated proteins in the structural stability and endopeptidase activity of botulinum neurotoxin complex types A and E.
Kukreja RV; Singh BR
Biochemistry; 2007 Dec; 46(49):14316-24. PubMed ID: 18004882
[TBL] [Abstract][Full Text] [Related]
9. Differential role of molten globule and protein folding in distinguishing unique features of botulinum neurotoxin.
Kumar R; Kukreja RV; Cai S; Singh BR
Biochim Biophys Acta; 2014 Jun; 1844(6):1145-52. PubMed ID: 24568862
[TBL] [Abstract][Full Text] [Related]
10. Toxic and nontoxic components of botulinum neurotoxin complex are evolved from a common ancestral zinc protein.
Inui K; Sagane Y; Miyata K; Miyashita S; Suzuki T; Shikamori Y; Ohyama T; Niwa K; Watanabe T
Biochem Biophys Res Commun; 2012 Mar; 419(3):500-4. PubMed ID: 22366035
[TBL] [Abstract][Full Text] [Related]
11. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme.
Ambrin G; Kumar R; Singh BR
Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744
[TBL] [Abstract][Full Text] [Related]
12. Molecular structures and functional relationships in clostridial neurotoxins.
Swaminathan S
FEBS J; 2011 Dec; 278(23):4467-85. PubMed ID: 21592305
[TBL] [Abstract][Full Text] [Related]
13. Transforming the domain structure of botulinum neurotoxins into novel therapeutics.
Chaddock J
Curr Top Microbiol Immunol; 2013; 364():287-306. PubMed ID: 23239358
[TBL] [Abstract][Full Text] [Related]
14. Role of the disulfide cleavage induced molten globule state of type a botulinum neurotoxin in its endopeptidase activity.
Cai S; Singh BR
Biochemistry; 2001 Dec; 40(50):15327-33. PubMed ID: 11735415
[TBL] [Abstract][Full Text] [Related]
15. Three enzymatically active neurotoxins of Clostridium botulinum strain Af84: BoNT/A2, /F4, and /F5.
Kalb SR; Baudys J; Smith TJ; Smith LA; Barr JR
Anal Chem; 2014 Apr; 86(7):3254-62. PubMed ID: 24605815
[TBL] [Abstract][Full Text] [Related]
16. Light Chain Diversity among the Botulinum Neurotoxins.
Gardner AP; Barbieri JT
Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30004421
[TBL] [Abstract][Full Text] [Related]
17. Subtyping botulinum neurotoxins by sequential multiple endoproteases in-gel digestion coupled with mass spectrometry.
Wang D; Baudys J; Rees J; Marshall KM; Kalb SR; Parks BA; Nowaczyk L; Pirkle JL; Barr JR
Anal Chem; 2012 Jun; 84(11):4652-8. PubMed ID: 22577857
[TBL] [Abstract][Full Text] [Related]
18. Exchange of the H(CC) domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin.
Rummel A; Mahrhold S; Bigalke H; Binz T
FEBS J; 2011 Dec; 278(23):4506-15. PubMed ID: 21624052
[TBL] [Abstract][Full Text] [Related]
19. Quaternary structure of botulinum and tetanus neurotoxins as probed by chemical cross-linking and native gel electrophoresis.
Ledoux DN; Be XH; Singh BR
Toxicon; 1994 Sep; 32(9):1095-104. PubMed ID: 7801345
[TBL] [Abstract][Full Text] [Related]
20. Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 A resolution.
Hanson MA; Stevens RC
Nat Struct Biol; 2000 Aug; 7(8):687-92. PubMed ID: 10932255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
